Moderna (MRNA) Down 92% from All-Time High – What's Next?

Overview:
Moderna (MRNA) has fallen sharply, trading 92% below its all-time high of $497.49 (reached in 2021). With this massive decline, investors might wonder: Is the stock poised for a recovery or headed lower?

Key Insights:

Support Levels:
Current price hovers near the 2020 pre-pandemic breakout zone (~$30-$40), a strong historical support area.

Catalysts to Watch:
Pipeline Updates: Moderna's future depends heavily on non-COVID vaccine developments. Any positive trial data could spark a rally. Broader Market Trends: If biotech stocks gain traction, MRNA could benefit as a high-beta play.